首页> 外文期刊>International Journal of Pharmaceutics >In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery
【24h】

In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery

机译:基于Pluronic F127 / Pluronic F68配方的原位胶凝系统,用于眼部药物输送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study evaluated the use of Pluronic F127 and Pluronic F68 as excipients for formulating in situ gelling systems for ocular drug delivery. Thermal transitions have been studied in aqueous solutions of Pluronic F127, Pluronic F68 as well as their binary mixtures using differential scanning calorimetry, rheological measurements, and dynamic light scattering. It was established that the formation of transparent gels at physiologically relevant temperatures is observed only in the case of 20 wt% of Pluronic F127. The addition of Pluronic F68 to Pluronic F127 solutions increases the gelation temperature of binary formulation to above physiological range of temperatures. The biocompatibility evaluation of these formulations using slug mucosa irritation assay and bovine corneal erosion studies revealed that these polymers and their combinations do not cause significant irritation. In vitro drug retention study on glass surfaces and freshly excised bovine cornea showed superior performance of 20 wt% Pluronic F127 compared to other formulations. In addition, in vivo studies in rabbits demonstrated better retention performance of 20 wt% Pluronic F127 compared to Pluronic F68. These results confirmed that 20 wt% Pluronic F127 offers an attractive ocular formulation that can form a transparent gel in situ under physiological conditions with minimal irritation. (C) 2016 Elsevier B.V. All rights reserved.
机译:这项研究评估了Pluronic F127和Pluronic F68作为赋形剂在配制用于眼部药物递送的原位胶凝系统中的用途。已经使用差示扫描量热法,流变学测量和动态光散射研究了Pluronic F127,Pluronic F68水溶液及其二元混合物中的热转变。已经确定,仅在20wt%的Pluronic F127的情况下才观察到在生理相关温度下透明凝胶的形成。在Pluronic F127溶液中添加Pluronic F68会使二元制剂的胶凝温度增加到高于生理温度范围。使用团状粘膜刺激测定法和牛角膜侵蚀研究对这些制剂的生物相容性评估表明,这些聚合物及其组合不会引起明显的刺激。在玻璃表面和新鲜切除的牛角膜上进行的体外药物保留研究显示,与其他配方相比,Pluronic F127具有20 wt%的优异性能。另外,在兔体内的研究表明,与Pluronic F68相比,20 wt%的Pluronic F127具有更好的保留性能。这些结果证实了20wt%的Pluronic F127提供了有吸引力的眼用制剂,其可以在生理条件下原位形成透明凝胶,并且刺激最小。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号